Skip to Main Content


Claire de Koeyer

Advising Catalent Pharma Solutions, Inc., a global listed pharmaceutical company headquartered in the U.S., in relation to the sale of 100% of its tablet and soft-gel capsule manufacturing facility in Victoria, Australia for AUD43.2 million to Blackmores Limited.
Advising on the application of the Australian Anti-Money Laundering and Counter-Terrorism Financing Act 2006 (Cth).
Assisting a foreign asset management company in obtaining ASIC registration in Australia.
Advising a global payment facility provider about the Australian regulation of non-cash payment facilities and assisting it to respond to inquiries from ASIC.
Advising a large technology company in relation to insurance products as financial products.
Advising superannuation fund trustees on regulatory requirements.
Advising one of Australia's major retail banks with its financial planning dealer group and private wealth regulatory compliance.
Reviewing Product Disclosure Statements for fund managers including to address ASIC's disclosure benchmark requirements.
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel